Evolution of the Average Target: Alcon Inc.

Evolution of the Target Price: Alcon Inc.

Changes in Analyst Recommendations: Alcon Inc.

4afc78c77583.q6xYXrQi3_V6s-ycgsOs3-ZHypXmko6AZqznvSF55vY._u0_a_5SvrwO5pj7yK_djpUh_efW6uThUZuC8kYcrZH4yAgEx1eFpyrj1A~0e4b7a431d8083de89e1e49fba3a4eac
09-11 Berenberg Sees Alcon as 'Best Way' into Ophthalmology Market Exposure; Buy Rating Affirmed MT
08-17 Deutsche Bank raises TP for Alcon, but shares down Zonebourse
08-13 BNP Paribas Downgrades Alcon to Neutral, Cuts PT MT
08-13 Bernstein Updates Alcon Estimates, Price Target After 'Strong' Commercial Execution in Q2 MT
08-11 Alcon: Q2 story: Innovation is being well received by the end market Alphavalue
05-25 Baptista Research Upgrades Alcon to Buy Rating MT
05-12 Swiss Market Index Closes Higher; SoftwareOne Shares Jump MT
05-08 Bernstein Keeps Alcon at Outperform After Q1 Results; Estimates, Price Target Revised MT
05-07 Needham Trims Price Target on Alcon to $95 From $100, Keeps Buy Rating MT
05-06 Alcon: Results weren't bad; today's correction is a buying opportunity Alphavalue
05-06 Alcon Price Target Declines as AlphaValue/Baader Cuts Estimates on Rising Competition, Expenses MT
05-06 Swiss stocks - Factors to watch on May 6 RE
05-05 Alcon: Investment case hinges on profitability expansion Alphavalue
04-21 RBC Bullish on Alcon's FY26 Growth Outlook; Outperform Maintained MT
03-19 AlphaValue/Baader Europe Upgrades Alcon to Add Rating, Lifts PT MT
03-16 Bernstein: Risk in Alcon's Implantables Business 'Manageable,' Already Priced In MT
03-10 Bernstein Says Alcon Top Pick in European Medtech Coverage, Notes 'Good Momentum' for Key Products into FY26 MT
03-06 Berenberg Keeps Alcon at Buy Amid Signs of US Cataract Market Rebound MT
03-04 Alcon Kept at Outperform as RBC Notes 'Positive Setup' Through FY26; Estimates Revised MT
02-27 Equita SIM Upgrades Alcon to Buy, Raises PT MT
02-26 Needham Raises Price Target on Alcon to $100 From $98, Keeps Buy Rating MT
02-26 Wells Fargo Upgrades Alcon AG to Overweight From Equal Weight, Adjusts PT to $97 From $88 MT
02-26 Alcon Estimates Tweaked as Bernstein Notes Potential Upside from End-market Recovery; Price Target Up MT
02-25 Alcon: Markets forgive Q4 miss for a healthy 2026 outlook Alphavalue
02-18 RBC Updates Alcon Estimates Ahead of FY25 Earnings; Outperform Rating Kept MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+40.96%
+68.23%
+1.32%
+23.13%
+54.6%
+33.77%
+50.02%
+0.21%
+39.93%
+26.4%
Average +33.86%
Weighted average by Cap. +50.84%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
64.83USD
Average target price
91.38USD
Spread / Average Target
+40.96%
High Price Target
105.27USD
Spread / Highest target
+62.39%
Low Price Target
59.24USD
Spread / Lowest Target
-8.61%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AAA
  1. Stock Market
  2. Stocks
  3. ALC Stock
  4. Consensus Alcon Inc.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!